Skip to main content
Hikma Pharmaceuticals PLC (LON:HIK)
London flag London · Delayed Price · Currency is GBP · Price in GBX
1,191.00
-18.00 (-1.49%)
At close: Mar 9, 2026

Hikma Pharmaceuticals Revenue

In the year 2025, Hikma Pharmaceuticals had annual revenue of $3.35B USD with 7.10% growth. Hikma Pharmaceuticals had revenue of $1.69B in the half year ending December 31, 2025, with 16.78% growth.

Revenue
$3.35B
Revenue Growth
+7.10%
P/S Ratio
1.07
Revenue / Employee
$356.28K
Employees
9,400
Market Cap
2.65B GBP

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20253.35B222.00M7.10%
Dec 31, 20243.13B252.00M8.77%
Dec 31, 20232.88B358.00M14.22%
Dec 31, 20222.52B-36.00M-1.41%
Dec 31, 20212.55B212.00M9.06%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
HUTCHMED (China) 407.54M
Allergy Therapeutics 55.04M
Haleon 11.03B
Animalcare Group 81.07M
Shield Therapeutics 30.29M
Venture Life Group 31.23M
ECO Animal Health Group 85.81M
Provexis 871.27K
Revenue Rankings

Hikma Pharmaceuticals News

More News